Related Experiment Videos
On the surgical treatment of refractory epilepsy in tuberous sclerosis complex
J E Baumgartner1, J W Wheless, S Kulkarni
1Division of Pediatric Surgery (Neurosurgery), The University of Texas Medical School, Houston 77030, USA. jbaumgar@utsurg.med.uth.tmc.edu
Insights
Surgery can significantly improve seizure control for individuals with tuberous sclerosis complex (TSC) and refractory epilepsy (RE). Focal cortical resection and temporal lobectomy offer promising outcomes for managing severe, drug-resistant seizures in TSC patients.
Area of Science:
- Neurology
- Neurosurgery
- Genetics
Background:
- Tuberous sclerosis complex (TSC) is a genetic disorder that can cause benign tumors to grow in various organs, including the brain.
- Refractory epilepsy (RE) is a common and debilitating symptom of TSC, often resistant to standard antiepileptic drug therapies.
- The efficacy of surgical interventions for RE in TSC remains incompletely understood.
Purpose of the Study:
- To evaluate the role and outcomes of epilepsy surgery in patients diagnosed with tuberous sclerosis complex and refractory epilepsy.
- To assess the effectiveness of temporal lobectomy and focal cortical resection in reducing seizure frequency in this patient population.
Main Methods:
- Retrospective evaluation of four patients with RE and TSC who underwent epilepsy surgery between 1994 and 1996.
- Pre-operative assessment included continuous video-EEG monitoring, neuroimaging (MRI), and in one case, magnetic source imaging.
- Surgical procedures involved temporal lobectomy or focal cortical resection, confirmed by intraoperative EEG.
Main Results:
- Three out of four patients experienced a significant seizure reduction (>90%) following surgery.
- Post-operative seizure activity was minimal, with one patient experiencing rare complex partial seizures and another rare simple partial seizures.
- Genetic analysis identified TSC1 gene mutations in one patient and TSC2 gene mutations in another; cases 3 and 4 remain genetically uncharacterized.
Conclusions:
- Temporal lobectomy and focal cortical resection represent viable surgical options for improving seizure control in patients with TSC and refractory epilepsy.
- Epilepsy surgery can lead to substantial and sustained seizure reduction in carefully selected TSC patients.
- Further research into genetic correlations and optimal surgical candidates is warranted.
Abstract:
The role of surgery in the treatment of refractory epilepsy (RE) in tuberous sclerosis complex (TSC) is poorly defined. Four patients with RE and TSC were evaluated for epilepsy surgery from 1994 to 1996. Three of four patients developed infantile spasms within 5 months of birth. These progressed to frequent complex partial and generalized tonic/myoclonic seizures refractory to antiepileptic drug therapy. Neuroimaging revealed typical findings of TSC including calcified lesions consistent with hamartomas. Clinical and EEG evidence suggested an epileptic focus near a prominent lesion in each child. This was confirmed using magnetic source imaging in 1 case. All patients underwent inpatient continuous video-EEG monitoring followed by temporal lobectomy or focal cortical resection with intraoperative EEG. Age at operation ranged from 5 to 13 years. Three out of 4 patients experienced a greater than 90% decrease in seizure activity. One patient continues to have rare complex partial seizures, and 1 has rare simple partial seizures. Tumor DNA analysis revealed mutations in the TSC1 gene in case 1 and the TSC2 gene in case 2; no mutations have been identified yet in cases 3 and 4. Temporal lobectomy and focal cortical resection can result in improved seizure control in patients with TSC and RE.